Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Johnson & Johnson
Woman Max 99 years
Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc
Update Il y a 4 ans
A PHASE 3 MULTI-CENTER PARALLEL DESIGN CLINICAL TRIAL TO COMPARE THE EFFICACY AND SAFETY OF 5% MINOXIDIL FOAM VS. 2% MINOXIDIL SOLUTION IN FEMALES FOR THE TREATMENT OF FEMALE PATTERN HAIR LOSS (ANDROGENETIC ALOPECIA)
To determine the risk/benefit profile of a 5% minoxidil topical foam (MTF) formulation applied OD for the treatment of female pattern hair loss FPHL) in comparison to 2% minoxidil topical solution (MT...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Johnson & Johnson Pharmaceutical Research and Development, L.L.C
Update Il y a 4 ans
A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy
The purpose of this study is to identify patient characteristics (such as baseline seizure frequency) that may predict effective doses of topiramate using just that one drug (monotherapy) as initial t...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Johnson & Johnson Pharmaceutical Research and Development, L.L.C
Update Il y a 4 ans
A study of the efficacy and tolerability of pancrelipase microtablet (MT) capsules for the treatment of cystic fibrosis-dependent exocrine pancreatic insufficiency
The purpose of this study is to assess the effectiveness and safety of oral pancrelipase MT in the treatment of adult and pediatric/adolescent cystic fibrosis (CF) patients with clinical symptoms of e...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Ethicon Inc., a Johnson & Johnson Co
Update Il y a 4 ans
A study of the safety and effectiveness of EVICEL® as a treatment in addition to standard techniques of joining the colon together
To evaluate the safety and effectiveness of EVICEL® Fibrin Sealant (Human) for use as an adjunct to stapled anastomosis after lower anterior resection (LAR). This will be done by assessing the abs...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Johnson & Johnson (USA)
Update Il y a 4 ans
Baby Skin Care Research Programme: Baby wipes study
Background and study aims We carried out our study because we have little good quality evidence about the effects of using baby cleansing wipes on young babies skin. Recent professional guidance stat...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Johnson & Johnson Pharmaceutical Research and Development
Update Il y a 4 ans
A Randomized Controlled Study of DOXIL/CAELYX (doxorubicin HCL liposome injection) and VELCADE (bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
The primary objective of this study is to test the hypothesis that treatment with DOXIL/CAELYX and VELCADE in combination, will result in a longer time to progression (TTP) than VELCADE monotherapy in...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Johnson & Johnson Pharmaceutical Research and Development, L.L.C
Update Il y a 4 ans
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
The purpose of this study is to evaluate the effectiveness (change in level of irritability and related behaviors) and safety and tolerability of the administration of 2 different fixed dose levels of...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Johnson & Johnson Pharmaceutical Research & Development, L.L.C
Update Il y a 4 ans
A Phase 3 Randomized, Double-Blind Study of Ceftobiprole Medocaril versus Linezolid Plus Ceftazidime in the Treatment of Nosocomial Pneumonia
Clinical cure rate, defined as the ratio of the number of clinically cured subjects to the total number of subjects in the population at TOC visit.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Johnson & Johnson Pharmaceutical Research & Development, L.L.C
Update Il y a 4 ans
A randomized withdrawal, active- and placebo-controlled, double-blind, multi-center Phase III trial assessing safety and efficacy of oral CG5503 PR* in subjects with moderate to severe chronic malignant tumor-related pain *PR means Prolonged Release and is the recommended nomenclature for use in EU. ER means Extended Release and is the recommended nomenclature for use in USA. "PR" is synonymous with "ER" and is interchangeable in the protocol
The primary objective of this trial is to evaluate the safety and efficacy orally administered CG5503 PR tablets BID over 4 weeks (Maintenance phase) in subjects with moderate to severe chronic malign...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Johnson & Johnson Pharmaceutical Research & Development, L.L.C
Update Il y a 4 ans
Pharmacokinetics and Safety of Doripenem in hospitalized Pediatric Patients from 3 Months to 17 Years of Age
The primary objective of this study is to assess the pharmacokinetics of doripenem and its metabolite, doripenem-M-1, in pediatric subjects 3 months to 17 years of age, inclusive.
Country
None
organs
None
Specialty
None
More information
1
2
3
4
Next